Literature DB >> 9665945

Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis.

E L Oleszak1, E Zaczynska, M Bhattacharjee, C Butunoi, A Legido, C D Katsetos.   

Abstract

We have examined the localization of inducible nitric oxide synthase (iNOS) and nitrotyrosine (the product of nitration of tyrosine by peroxynitrite, a highly reactive derivative of nitric oxide [NO]) in demyelinating lesions from (i) two young adult patients with acute multiple sclerosis (MS), (ii) a child with MS (consistent with diffuse sclerosis), and (iii) five adult patients with chronic MS. Previous reports have suggested a possible correlation between iNOS, peroxynitrite, related nitrogen-derived oxidants, and the demyelinating processes in MS. We have demonstrated iNOS-immunoreactive cells in both acute-MS and diffuse-sclerosis-type lesions. In acute-MS lesions, iNOS was localized in both monocytes/macrophages and reactive astrocytes. However, foamy (myelin-laden) macrophages and the majority of reactive astrocytes were iNOS negative. In specimens from the childhood MS patient, iNOS protein was present only in a subpopulation of reactive or hypertrophic astrocytes. In contrast, no iNOS staining was detected in chronic-MS lesions. Immunohistochemical staining of acute-MS lesions with an antibody to nitrotyrosine revealed codistribution of iNOS- and nitrotyrosine-positive cells, although nitrotyrosine staining was more widespread in cells of the monocyte/macrophage lineage. In diffuse-sclerosis-type lesions, nitrotyrosine staining was present in hypertrophic astrocytes, whereas it was absent in chronic-MS lesions. These results suggest that NO and nitrogen-derived oxidants may play a role in the initiation of demyelination in acute-MS lesions but not in the later phase of the disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665945      PMCID: PMC95596          DOI: 10.1128/CDLI.5.4.438-445.1998

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  68 in total

Review 1.  Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus.

Authors:  M Rodriguez; E Oleszak; J Leibowitz
Journal:  Crit Rev Immunol       Date:  1987       Impact factor: 2.214

2.  Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.

Authors:  V L Dawson; T M Dawson; E D London; D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

Review 3.  The role of nitric oxide in multiple sclerosis.

Authors:  J F Parkinson; B Mitrovic; J E Merrill
Journal:  J Mol Med (Berl)       Date:  1997-03       Impact factor: 4.599

4.  Epitope spreading occurs in active but not passive EAE induced by myelin basic protein.

Authors:  R R Voskuhl; R W Farris; K Nagasato; H F McFarland; M D Dalcq
Journal:  J Neuroimmunol       Date:  1996-11       Impact factor: 3.478

5.  Chemical influences on the specificity of tyrosine phosphorylation.

Authors:  B L Martin; D Wu; S Jakes; D J Graves
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

6.  Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions.

Authors:  C J De Groot; S R Ruuls; J W Theeuwes; C D Dijkstra; P Van der Valk
Journal:  J Neuropathol Exp Neurol       Date:  1997-01       Impact factor: 3.685

7.  Macrophage histology in paraffin-embedded multiple sclerosis plaques is demonstrated by the monoclonal pan-macrophage marker HAM-56: correlation with chronicity of the lesion.

Authors:  C W Adams; R N Poston
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

8.  Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide.

Authors:  R Radi; J S Beckman; K M Bush; B A Freeman
Journal:  J Biol Chem       Date:  1991-03-05       Impact factor: 5.157

9.  Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients.

Authors:  M I Hunter; B C Nlemadim; D L Davidson
Journal:  Neurochem Res       Date:  1985-12       Impact factor: 3.996

10.  Evidence of neuronal oxidative damage in Alzheimer's disease.

Authors:  P F Good; P Werner; A Hsu; C W Olanow; D P Perl
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

View more
  34 in total

1.  Denitration of peroxynitrite-treated proteins by 'protein nitratases' from rat brain and heart.

Authors:  W N Kuo; R N Kanadia; V P Shanbhag; R Toro
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

2.  Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis.

Authors:  K Rejdak; A Petzold; T Kocki; J Kurzepa; P Grieb; W A Turski; Z Stelmasiak
Journal:  J Neural Transm (Vienna)       Date:  2007-03-29       Impact factor: 3.575

3.  An immunohistochemical study of nitrotyrosine expression in pancreatic islets of cases with increasing duration of type 1 diabetes and without diabetes.

Authors:  Charlton Martin; Lars Krogvold; Shebani Farik; Satya Amirapu; Fiona Wu; Shiva Reddy; Knut Dahl-Jørgensen
Journal:  Histochem Cell Biol       Date:  2017-02-02       Impact factor: 4.304

Review 4.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

5.  In vitro detection of apoptosis in monocytes/macrophages infected with human coronavirus.

Authors:  Arlene R Collins
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 6.  Inflammation induced neurological handicap processes in multiple sclerosis: new insights from preclinical studies.

Authors:  Klaus G Petry; Bruno Brochet; Vincent Dousset; Jean Rodolphe Vignes; Claudine Boiziau
Journal:  J Neural Transm (Vienna)       Date:  2010-06-23       Impact factor: 3.575

7.  In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis.

Authors:  In-Young Choi; Phil Lee; Peter Adany; Abbey J Hughes; Scott Belliston; Douglas R Denney; Sharon G Lynch
Journal:  Mult Scler       Date:  2017-06-01       Impact factor: 6.312

Review 8.  Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria.

Authors:  Guy C Brown; Anna Bal-Price
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

Review 9.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

Review 10.  Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making.

Authors:  Violaine K Harris; Saud A Sadiq
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.